Relay Therapeutics, Inc.RLAYNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank43
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-302.74M
↓ 27% vs avg
Percentile
P43
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-237.74M
Historical baseline
PeriodValueYoY Change
TTM$-302.74M+18.7%
2024$-372.47M+0.1%
2023$-373.00M-24.6%
2022$-299.27M+17.9%
2021$-364.70M-553.6%
2020$-55.80M+33.6%
2019$-84.05M-68.5%
2018$-49.89M-